Blepharitis other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Dynamic meibomian imaging (DMI) may be used to detect ductal gland dilation, dropout, or gland atrophy, which are commonly observed in [[meibomian gland]] dysfunction secondary to blepharitis. DMI can also be used to obtain a clear view of the entire everted inferior [[tarsal plate]] in blepharitis cases concurrent with [[dry eye syndrome]]. | |||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===Dynamic Meibomian Imaging=== | ===Dynamic Meibomian Imaging=== | ||
Dynamic meibomian imaging (DMI) | Dynamic meibomian imaging (DMI) may be used to detect ductal gland dilation, dropout, or gland atrophy, which are commonly observed in [[meibomian gland]] dysfunction secondary to blepharitis. DMI can also be used to obtain a clear view of the entire everted inferior [[tarsal plate]] in blepharitis cases concurrent with [[dry eye syndrome]].<ref name="pmid8779082">{{cite journal| author=Driver PJ, Lemp MA| title=Meibomian gland dysfunction. | journal=Surv Ophthalmol | year= 1996 | volume= 40 | issue= 5 | pages= 343-67 | pmid=8779082 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8779082 }} </ref><ref name="pmid24696045">{{cite journal| author=Qazi Y, Aggarwal S, Hamrah P| title=Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. | journal=Graefes Arch Clin Exp Ophthalmol | year= 2014 | volume= 252 | issue= 6 | pages= 857-72 | pmid=24696045 | doi=10.1007/s00417-014-2618-2 | pmc=4038672 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24696045 }} </ref> | ||
==References== | ==References== | ||
| Line 15: | Line 16: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
Revision as of 15:51, 12 September 2016
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis other imaging findings On the Web | |
|
American Roentgen Ray Society Images of Blepharitis other imaging findings | |
|
Risk calculators and risk factors for Blepharitis other imaging findings | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Dynamic meibomian imaging (DMI) may be used to detect ductal gland dilation, dropout, or gland atrophy, which are commonly observed in meibomian gland dysfunction secondary to blepharitis. DMI can also be used to obtain a clear view of the entire everted inferior tarsal plate in blepharitis cases concurrent with dry eye syndrome.
Other Imaging Findings
Dynamic Meibomian Imaging
Dynamic meibomian imaging (DMI) may be used to detect ductal gland dilation, dropout, or gland atrophy, which are commonly observed in meibomian gland dysfunction secondary to blepharitis. DMI can also be used to obtain a clear view of the entire everted inferior tarsal plate in blepharitis cases concurrent with dry eye syndrome.[1][2]
References
- ↑ Driver PJ, Lemp MA (1996). "Meibomian gland dysfunction". Surv Ophthalmol. 40 (5): 343–67. PMID 8779082.
- ↑ Qazi Y, Aggarwal S, Hamrah P (2014). "Image-guided evaluation and monitoring of treatment response in patients with dry eye disease". Graefes Arch Clin Exp Ophthalmol. 252 (6): 857–72. doi:10.1007/s00417-014-2618-2. PMC 4038672. PMID 24696045.